US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 2.820
  • 0.0000.00%
Close Mar 28 16:00 ET
22.86MMarket Cap-674P/E (TTM)

Lumos Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.80%-31.1M
-26.90%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.20%-26.62M
-0.26%-5.83M
21.67%-5.52M
-13.58%-7.25M
22.85%-8.03M
Net income from continuing operations
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-13.86%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
9.53%-7.84M
10.55%-7.72M
Depreciation and amortization
-10.20%44K
-48.57%18K
100.00%8K
550.00%9K
-25.00%9K
-77.42%49K
34.62%35K
100.00%4K
-110.53%-2K
-92.94%12K
Other non cash items
-1,407.69%-392K
---30K
---91K
---135K
---136K
---26K
----
----
----
----
Change In working capital
-53.96%965K
-14.96%1.55M
-99.65%4K
6,511.54%1.72M
-159.55%-2.31M
190.58%2.1M
364.49%1.83M
2,370.00%1.14M
-98.18%26K
70.33%-890K
-Change in receivables
114.13%13K
13.64%-38K
481.25%61K
-28.00%-32K
414.29%22K
-167.65%-92K
-266.67%-44K
-277.78%-16K
-136.23%-25K
-110.00%-7K
-Change in prepaid assets
38.01%679K
42.39%833K
-32.20%320K
-61.33%169K
35.83%-643K
145.30%492K
135.89%585K
-29.13%472K
225.21%437K
39.31%-1M
-Change in payables and accrued expense
-83.90%273K
-41.04%757K
-155.52%-377K
509.84%1.58M
-1,519.33%-1.69M
224.34%1.7M
238.66%1.28M
193.66%679K
-122.63%-386K
108.39%119K
Cash from discontinued investing activities
Operating cash flow
-16.80%-31.1M
-26.90%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.20%-26.62M
-0.26%-5.83M
21.67%-5.52M
-13.58%-7.25M
22.85%-8.03M
Investing cash flow
Cash flow from continuing investing activities
194.58%10.74M
154.34%6.17M
5.95M
1.08M
-2.46M
-143.74%-11.36M
-37,760.00%-11.36M
0
0
0
Net PPE purchase and sale
--0
----
----
----
----
30.00%-21K
----
----
----
----
Net investment purchase and sale
194.75%10.74M
154.44%6.17M
--5.95M
--1.08M
---2.46M
---11.34M
---11.34M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
194.58%10.74M
154.34%6.17M
--5.95M
--1.08M
---2.46M
-143.74%-11.36M
-37,760.00%-11.36M
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
29.84%-576K
256.21%742K
-33.44%-435K
-28,600.00%-574K
-1,616.67%-309K
-327.60%-821K
-475K
-326K
92.31%-2K
89.16%-18K
Net common stock issuance
13.33%-585K
251.67%725K
-116.24%-426K
---579K
---305K
---675K
---478K
---197K
--0
--0
Proceeds from stock option exercised by employees
-60.67%35K
-29.17%17K
--0
----
----
27.14%89K
--24K
--35K
----
----
Net other financing activities
88.94%-26K
--0
94.51%-9K
59.38%-13K
77.78%-4K
10.31%-235K
---21K
---164K
54.29%-32K
90.63%-18K
Cash from discontinued financing activities
Financing cash flow
29.84%-576K
256.21%742K
-33.44%-435K
-28,600.00%-574K
-1,616.67%-309K
-327.60%-821K
---475K
---326K
92.31%-2K
89.16%-18K
Net cash flow
Beginning cash position
-40.93%56.01M
-51.73%35.56M
-52.38%37.86M
-49.24%44.04M
-40.93%56.01M
-3.92%94.81M
-26.81%73.67M
-26.17%79.51M
-23.96%86.76M
-3.92%94.81M
Current changes in cash
46.06%-20.93M
97.29%-479K
60.56%-2.31M
14.78%-6.18M
-48.66%-11.97M
-902.64%-38.8M
-202.33%-17.66M
17.05%-5.85M
-13.15%-7.25M
-152.20%-8.05M
End cash Position
-37.37%35.08M
-37.37%35.08M
-51.73%35.56M
-52.38%37.86M
-49.24%44.04M
-40.93%56.01M
-40.93%56.01M
-26.81%73.67M
-26.17%79.51M
-23.96%86.76M
Free cash flow
-16.71%-31.1M
-26.44%-7.39M
-41.69%-7.82M
7.73%-6.69M
-14.49%-9.2M
10.22%-26.64M
-0.10%-5.85M
21.67%-5.52M
-13.58%-7.25M
22.85%-8.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.80%-31.1M-26.90%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.20%-26.62M-0.26%-5.83M21.67%-5.52M-13.58%-7.25M22.85%-8.03M
Net income from continuing operations -9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-13.86%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M9.53%-7.84M10.55%-7.72M
Depreciation and amortization -10.20%44K-48.57%18K100.00%8K550.00%9K-25.00%9K-77.42%49K34.62%35K100.00%4K-110.53%-2K-92.94%12K
Other non cash items -1,407.69%-392K---30K---91K---135K---136K---26K----------------
Change In working capital -53.96%965K-14.96%1.55M-99.65%4K6,511.54%1.72M-159.55%-2.31M190.58%2.1M364.49%1.83M2,370.00%1.14M-98.18%26K70.33%-890K
-Change in receivables 114.13%13K13.64%-38K481.25%61K-28.00%-32K414.29%22K-167.65%-92K-266.67%-44K-277.78%-16K-136.23%-25K-110.00%-7K
-Change in prepaid assets 38.01%679K42.39%833K-32.20%320K-61.33%169K35.83%-643K145.30%492K135.89%585K-29.13%472K225.21%437K39.31%-1M
-Change in payables and accrued expense -83.90%273K-41.04%757K-155.52%-377K509.84%1.58M-1,519.33%-1.69M224.34%1.7M238.66%1.28M193.66%679K-122.63%-386K108.39%119K
Cash from discontinued investing activities
Operating cash flow -16.80%-31.1M-26.90%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.20%-26.62M-0.26%-5.83M21.67%-5.52M-13.58%-7.25M22.85%-8.03M
Investing cash flow
Cash flow from continuing investing activities 194.58%10.74M154.34%6.17M5.95M1.08M-2.46M-143.74%-11.36M-37,760.00%-11.36M000
Net PPE purchase and sale --0----------------30.00%-21K----------------
Net investment purchase and sale 194.75%10.74M154.44%6.17M--5.95M--1.08M---2.46M---11.34M---11.34M--0--0--0
Cash from discontinued investing activities
Investing cash flow 194.58%10.74M154.34%6.17M--5.95M--1.08M---2.46M-143.74%-11.36M-37,760.00%-11.36M--0--0--0
Financing cash flow
Cash flow from continuing financing activities 29.84%-576K256.21%742K-33.44%-435K-28,600.00%-574K-1,616.67%-309K-327.60%-821K-475K-326K92.31%-2K89.16%-18K
Net common stock issuance 13.33%-585K251.67%725K-116.24%-426K---579K---305K---675K---478K---197K--0--0
Proceeds from stock option exercised by employees -60.67%35K-29.17%17K--0--------27.14%89K--24K--35K--------
Net other financing activities 88.94%-26K--094.51%-9K59.38%-13K77.78%-4K10.31%-235K---21K---164K54.29%-32K90.63%-18K
Cash from discontinued financing activities
Financing cash flow 29.84%-576K256.21%742K-33.44%-435K-28,600.00%-574K-1,616.67%-309K-327.60%-821K---475K---326K92.31%-2K89.16%-18K
Net cash flow
Beginning cash position -40.93%56.01M-51.73%35.56M-52.38%37.86M-49.24%44.04M-40.93%56.01M-3.92%94.81M-26.81%73.67M-26.17%79.51M-23.96%86.76M-3.92%94.81M
Current changes in cash 46.06%-20.93M97.29%-479K60.56%-2.31M14.78%-6.18M-48.66%-11.97M-902.64%-38.8M-202.33%-17.66M17.05%-5.85M-13.15%-7.25M-152.20%-8.05M
End cash Position -37.37%35.08M-37.37%35.08M-51.73%35.56M-52.38%37.86M-49.24%44.04M-40.93%56.01M-40.93%56.01M-26.81%73.67M-26.17%79.51M-23.96%86.76M
Free cash flow -16.71%-31.1M-26.44%-7.39M-41.69%-7.82M7.73%-6.69M-14.49%-9.2M10.22%-26.64M-0.10%-5.85M21.67%-5.52M-13.58%-7.25M22.85%-8.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg